Occupational Therapists in Blue Point, NY Accepting Medicare
7 Occupational Therapists found. Showing 1 - 7
 Jessica Acevedo, COTA/L Occupational Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 235 Blue Point Ave, Blue Point, NY 11715 Phone: 631-363-5794 |
Denise Remski, OT Occupational Therapist - Pediatrics Medicare: Medicare Enrolled Practice Location: 235 Blue Point Ave, Blue Point, NY 11715 Phone: 631-363-5794 |
Ms. Laura Anne Trent, OTR Occupational Therapist Medicare: Medicare Enrolled Practice Location: 12 Corky Ct, Blue Point, NY 11715 Phone: 631-868-3313 |
Jessica Spatarella, OT Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 35 Smith St, Blue Point, NY 11715 Phone: 631-275-3045 |
Nicole Kelly Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 65 Middle Rd, Blue Point, NY 11715 Phone: 631-294-3779 |
 Gregory Glover, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 235 Blue Point Ave, # A, Blue Point, NY 11715 Phone: 631-363-5794 |
Caitlin Patricia Mitchell, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 33 Namkee Rd, Blue Point, NY 11715 Phone: 631-363-6412 |
News Archive
Alecensa (alectinib) approved for treatment of people with advanced ALK-positive NSCLC
The U.S. Food and Drug Administration today approved Alecensa (alectinib) to treat people with advanced (metastatic) ALK-positive non-small cell lung cancer (NSCLC) whose disease has worsened after, or who could not tolerate treatment with, another therapy called Xalkori (crizotinib).
Research reveals genetic conversation between X and Y chromosomes
In the week that the University of Leicester celebrates the 25th anniversary of the discovery of DNA fingerprinting (Thursday September 10) new findings from the world-renowned University of Leicester Department of Genetics reveal for the first time that the male and female do truly communicate -at least at the fundamental genetic level.
Evolvent assists DoD progress towards National Health Information Network
Evolvent Technologies, Inc., a leading provider of healthcare information technology services to the Federal Government, is assisting the Department of Defense (DoD) progress towards the National Health Information Network (NHIN).
Mount Sinai researchers receive NIH award to develop universal flu vaccine
Researchers at the Icahn School of Medicine at Mount Sinai have received a contract award of up to $132 million from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH), as part of a new Collaborative Influenza Vaccine Innovation Centers (CIVICs) program to further develop the universal flu vaccine.
› Verified 7 days ago
Speech-Language Pathologists
Occupational Therapists
Chiropractors
Physical Therapists